Skip to main content
microLife logoLink to microLife
. 2023 Jan 28;4:uqad005. doi: 10.1093/femsml/uqad005

Cyclic di-AMP, a multifaceted regulator of central metabolism and osmolyte homeostasis in Listeria monocytogenes

Inge Schwedt 1, Mengyi Wang 2, Johannes Gibhardt 3, Fabian M Commichau 4,
PMCID: PMC10117814  PMID: 37223746

Abstract

Cyclic di-AMP is an emerging second messenger that is synthesized by many archaea and bacteria, including the Gram-positive pathogenic bacterium Listeria monocytogenes. Listeria monocytogenes played a crucial role in elucidating the essential function of c-di-AMP, thereby becoming a model system for studying c-di-AMP metabolism and the influence of the nucleotide on cell physiology. c-di-AMP is synthesized by a diadenylate cyclase and degraded by two phosphodiesterases. To date, eight c-di-AMP receptor proteins have been identified in L. monocytogenes, including one that indirectly controls the uptake of osmotically active peptides and thus the cellular turgor. The functions of two c-di-AMP-receptor proteins still need to be elucidated. Here, we provide an overview of c-di-AMP signalling in L. monocytogenes and highlight the main differences compared to the other established model systems in which c-di-AMP metabolism is investigated. Moreover, we discuss the most important questions that need to be answered to fully understand the role of c-di-AMP in osmoregulation and in the control of central metabolism.

Keywords: Osmolyte, osmoregulation, CodY, essential gene, second messenger, turgor


In this review, we provide an overview of c-di-AMP signalling in L. monocytogenes, highlight differences to other model systems, and discuss open questions that urgently need to be addressed.

Introduction

Cyclic di-AMP was first discovered during structural and functional characterization of the DNA integrity scanning protein A (DisA) homologs from Thermotoga maritima and Bacillus subtilis (Witte et al. 2008). DisA has previously been shown to be a non-specific DNA-binding protein that detects chromosomal damage in B. subtilis (Bejerano-Sagie et al. 2006). Shortly thereafter, the observation that the overproduction of the multidrug resistance (MDR) transporter MdrM in Listeria monocytogenes correlated with increased activation of the mammalian innate immune system led to the identification of c-di-AMP in this organism (Fig. 1) (Crimmins et al. 2008, Woodward et al. 2010). The single c-di-AMP synthesizing enzyme CdaA in L. monocytogenes is essential for growth under standard cultivation conditions (Woodward et al. 2010). Next, c-di-AMP was shown to be produced by many bacteria among them B. subtilis, Chlamydia trachomatis Lactococcus lactis, Mycobacterium tuberculosis, Mycoplasma pneumoniae, Staphylococcus aureus and Streptococcus pneumoniae (Corrigan et al. 2011, Luo and Helmann 2012, Bai et al. 2013, Barker et al. 2013, Mehne et al. 2013, Manikandan et al. 2014, Zhu et al. 2016, Blötz et al. 2017). Albeit less well studied, it has also been shown that archaea synthesize c-di-AMP (Kellenberger et al. 2015, Braun et al. 2019, Braun et al. 2021). Although the groups of organisms are phylogenetically distantly related, an important function of c-di-AMP in bacteria and archaea is the control of osmolyte homeostasis (see below).

Figure 1.

Figure 1.

Schematic illustration of c-di-AMP signalling in L. monocytogenes (modified from Wang et al. 2022). CdaR and GlmM modulate the activity of CdaA. c-di-AMP is secreted by multidrug efflux pumps (MDRs) and degraded by the phosphodiesterases GdpP and PgpH to 5′-pApA. The nanoRNase NrnA converts 5′pApA to AMP. The uptake of potassium and carnitine is inhibited by c-di-AMP that also interacts with the sensor kinase of the putative kdpABC potassium transporter genes. c-di-AMP indirectly controls the CodY-dependent expression of the opp oligopeptide transporter genes via CbpB-dependent regulation of Rel activity. The Opp system is involved in the uptake of bialaphos and fosfomycin of which the latter is also imported by the hexose phosphate transporter Hpt. Fosfomycin inhibits the UDP-N-acetylglucosamine 1-carboxyvinyltransferase MurA. The activity of the PycA pyruvate carboxylase is allosterically regulated by c-di-AMP. The functions of the c-di-AMP receptor proteins CbpA and PstA are unknown.

In addition to the cyclases DisA and CdaA, the cyclases CdaS, CdaM and CdaZ have been described (Corrigan and Gründling 2013, Commichau et al. 2019, Stülke and Krüger 2020). While the diadenylate cyclases of the CdaA- and CdaM-type are membrane-bound enzymes, the remaining three cyclases are soluble. Interestingly, bacteria such as Clostridioides difficile and B. subtilis produce two (DisA and CdaA) and three (CdaA, DisA and CdaS) diadenylate cyclases, respectively (Luo and Helmann 2012, Mehne et al. 2013, Oberkampf et al 2022). Since both, B. subtilis and C. difficile are spore forming bacteria, it was hypothesized that c-di-AMP plays a role in the developmental process of sporulation. Indeed, for B. subtilis it has been observed that the cyclases DisA and CdaS are involved in the initiation of spore formation and germination, respectively (Bejerano-Sagie et al. 2006, Mehne et al. 2014). The diadenylate cyclase of the CdaA-type is the most widespread cyclase that has been well studied biochemically and structurally (Rosenberg et al. 2015, Heidemann et al. 2019). Since CdaA is the only diadenylate cyclase in many pathogenic bacteria like S. aureus, S. pneumoniae and L. monocytogenes, the essential enzyme is an excellent target for novel antibiotics.

Bacterial secretion of c-di-AMP via the MDR transporter MdrA, including MdrC, MdrM, MdrL and MdrT, is considered as one possibility to decrease the intracellular c-di-AMP concentration (Fig. 1) (Crimmins et al. 2008, Woodward et al. 2010, Schwartz et al. 2012, Yamamoto et al. 2012, Kaplan Zeevi et al. 2013, Tadmor et al. 2014). Bacteria synthesizing c-di-AMP also possess specific phosphodiesterases that degrade the second messenger. So far, five different types of phosphodiesterases have been identified and characterized (Pham et al. 2016, Stülke and Krüger 2020). The GdpP- and PgpH-type phosphodiesterases localize at the membrane, the DhhP- and AtaC-type phosphodiesterases are soluble enzymes (Commichau et al. 2019, Latoscha et al. 2020) and CdnP-type phosphodiesterases are exposed to the cell surface (see below) (Andrade et al. 2016). Since c-di-AMP controls the uptake and efflux of osmolytes in bacteria depending on the environmental osmolarity, the adjustment of the cellular c-di-AMP concentration by synthesis, secretion or degradation is crucial for the viability of the cell (Corrigan et al. 2013, Nelson et al. 2013, Bai et al. 2014, Chin et al. 2015, Moscoso et al. 2015, Huynh et al. 2016, Schuster et al. 2016, Gundlach et al. 2017, Devaux et al. 2018a, Rubin et al. 2018, Zeden et al. 2018, Quintana et al. 2019, Wang et al. 2019, Krüger et al. 2020, Sikkema et al. 2020, Cereija et al. 2021, Pham et al. 2021). In fact, c-di-AMP is a key factor essential for osmoregulation in many bacteria and archaea (Commichau et al. 2018, Braun et al. 2019). c-di-AMP is also involved in the control of central metabolism (Sureka et al. 2014, Choi et al. 2017, Whiteley et al. 2017), glycogen metabolism (Selim et al. 2021), DNA damage repair caused by hydrogen peroxide (Gándara and Alonso 2015), cell wall metabolism (Witte et al. 2013, St Onge and Elliot 2017, Massa et al. 2020), biofilm formation (Du et al. 2014, Gundlach et al. 2016, Peng et al. 2016, Townsley et al. 2018, Fahmi et al. 2019, The et al. 2019, Faozia et al. 2021, Rorvik et al. 2021, Wang et al. 2022) and in genetic competence (Zarrella et al. 2020). Some bacteria like the human pathogen Streptococcus agalactiae produce the extracellular phosphodiesterase CdnP that is attached to the cell envelope (Andrade et al. 2016). CdnP is required to decrease the activation of the innate immune system by c-di-AMP that is secreted by the bacteria to the environment (Andrade et al. 2016, Devaux et al.2018b).

Since the discovery of c-di-AMP, many targets have been identified that are bound and regulated by the nucleotide (He et al. 2020, Yin et al. 2020). For instance, c-di-AMP inhibits and activates potassium uptake and efflux systems, respectively, in bacteria (Stülke and Krüger 2020). c-di-AMP also controls the expression of genes encoding osmolyte transporters by binding to a conserved riboswitch and to DNA-binding transcription factors (Block et al. 2010, Nelson et al. 2013, Gao and Serganov 2014, Ren and Patel 2014, Gundlach et al. 2017, Devaux et al. 2018a, Pham et al. 2018, Wang et al. 2019, Bandera et al. 2021, Oberkampf et al 2022). Recently, it was shown that the apo form of the c-di-AMP-receptor protein DarB in B. subtilis directly binds to the pyruvate carboxylase and the (p)ppGpp-synthetase/hydrolase, thereby controlling the flux through central carbon metabolism and stringent response, respectively (Krüger et al. 2021a, 2022). While for many c-di-AMP targets it has been elucidated how the nucleotide influences their activity, there are still targets whose function are unknown, including the PII-like signal transduction protein DarA in B. subtilis (PstA in L. monocytogenes and S. aureus) and L. monocytogenes CbpA (Campeotto et al. 2015, Choi et al. 2015, Gundlach et al. 2015a, Müller et al. 2015).

We are interested in c-di-AMP metabolism in the human pathogen L. monocytogenes. Along with B. subtilis, S. aureus and several other bacteria as well as archaea, L. monocytogenes has become an important model system for studying c-di-AMP metabolism and the impact of the nucleotide on cell physiology. Here we provide an overview of c-di-AMP signalling in L. monocytogenes and discuss issues that need to be addressed to fully understand the physiological functions of c-di-AMP.

c-di-AMP synthesizing and degrading enzymes in L. Monocytogenes

In contrast to B. subtilis and C. difficile, L. monocytogenes only synthesizes the CdaA-type diadenylate cyclase, which is encoded by the essential cdaA gene in the conserved cdaR-cdaA-glmM module that also codes for the essential phosphoglucosamine mutase GlmM and the regulatory CdaR protein (Rismondo et al. 2016, Gibhardt et al. 2020, Fischer et al. 2022). CdaA is inserted into the membrane via three N-terminally located hydrophobic helices that are not required for in vitro activity of the cyclase (Fig. 1) (Rosenberg et al. 2015, Rismondo et al. 2016). The c-di-AMP-synthesizing diadenylate cyclase domain, which is surrounded by two coiled coil (CC) motifs is located at the C-terminus of CdaA (Rosenberg et al. 2015). In all diadenylate cyclases known so far, the catalytic domain is fused to other protein domains that control c-di-AMP synthesis (Corrigan and Gründling 2013, Commichau et al. 2019). For the sporulation-specific diadenylate cyclase CdaS in B. subtilis it has been shown that the two N-terminally-located helices are important for negative control of the diadenylate cyclase domain (Mehne et al. 2013). It is tempting to speculate that also the N-terminal transmembrane helices and CC motifs are required for sensing yet unknown stimuli to control the diadenylate cyclase domain of CdaA in vivo (see below). The N-terminally truncated L. monocytogenes diadenylate cyclase CdaA lacking the transmembrane helices has been structurally characterized (Rosenberg et al. 2015, Heidemann et al. 2019). Like in DisA, the synthesis of c-di-AMP from two molecules of ATP requires the formation of CdaA dimers for proper arrangement of the important residues of the diadenylate cyclase domain in a face-to-face fashion (Rosenberg et al. 2015, Heidemann et al. 2019). It has been suggested that the full-length CdaA enzyme from S. aureus forms multimers consisting of two interacting dimers (Tosi et al. 2019). However, the formation of CdaA multimers in vivo has yet to be demonstrated. In contrast to other diadenylate cyclases from Bacillus thuringiensis, M. tuberculosis and T. maritima that require magnesium ions for enzyme catalysis (Witte et al. 2008, Bai et al. 2012, Zheng et al. 2013), CdaA from L. monocytogenes depends on manganese ions (Rosenberg et al. 2015, Heidemann et al. 2019). It would be interesting to elucidate whether the full-length CdaA protein also depends on manganese for c-di-AMP synthesis.

Listeria monocytogenes secretes c-di-AMP via MDR transporters MdrA, MdrC, MdrM, MdrL, and MdrT, (Crimmins et al. 2008, Woodward et al. 2010, Schwartz et al. 2012, Yamamoto et al. 2012, Kaplan Zeevi et al. 2013, Tadmor et al. 2014, Huynh and Woodward 2016) and the nucleotide can be degraded by GdpP and PgpH to 5′-pApA (Fig. 1) (Kaplan Zeevi et al. 2013, Witte et al. 2013, Huynh et al. 2015, Hyunh and Woodward 2016, Massa et al. 2020, Wang et al. 2022). The linear nucleotide 5′-pApA is further degraded by NrnA in L. monocytogenes (Gall et al. 2022). The phosphodiesterase GdpP (GGDEF domain protein-containing phosphodiesterase; PdeA in L. monocytogenes) is present in many Firmicutes (Rallu et al. 2000, Commichau et al. 2019). GdpP-type phosphodiesterases contain two N-terminal transmembrane helices, a PAS (Per-Arnt-Sim) domain, a degenerate GGDEF domain and a C-terminal DHH and DHHA1 domains (Hyunh and Woodward 2016, Commichau et al. 2019). So far, it has been shown that b-type heme binds to the PAS domain and inhibits the ATPase activity of the phosphodiesterase GdpP and nitric oxide stimulates the enzyme (Fig. 1) (Rao et al. 2010, 2011, Tan et al. 2013). The GdpP-type phosphodiesterases are also inhibited in a competitive manner by the bacterial alarmone (p)ppGpp (Rao et al. 2010, Corrigan et al. 2015; Bowman et al. 2016; Wang et al. 2017). The (p)ppGpp-dependent inhibition of GdpP must occur because the lack of c-di-AMP results in the activation of Rel (Fig. 1) (Peterson et al. 2020, Krüger et al. 2021a) (see below). The phosphodiesterase of the PgpH-type is also a membrane-bound enzyme and contains eight transmembrane helices (Fig.   1) (Liu et al. 2006, Huynh et al. 2015, Hyunh and Woodward 2016). An extracellular seven-transmembrane helix-HDED (7TMR-HDED) domain is located between the transmembrane helices 1 and 2 and the metal-dependent HD phosphohydrolase domain is present in the cytosol (Fig. 1A). As shown for GdpP, (p)ppGpp also inhibits PgpH (Huynh et al. 2015). For both phosphodiesterases of L. monocytogenes it will be interesting to identify the extracellular signals that are sensed by the enzymes (see below).

The essential function of c-di-AMP in L. Monocytogenes

As mentioned above, c-di-AMP is essential for bacteria like B. subtilis, L. monocytogenes, and S. aureus (Whiteley et al. 2015, Gundlach et al. 2017, Zeden et al. 2018). A genetic approach in combination with a suppressor analysis revealed that a c-di-AMP-free L. monocytogenes strain is viable on complex medium if the Opp and Gbu transport systems for the uptake of peptides and glycine betaine, respectively, were inactivated (Whiteley et al. 2015). The same study also identified the link between c-di-AMP metabolism and (p)ppGpp synthesis because some cdaA suppressor mutants accumulated mutations in the rel gene that reduced the (p)ppGpp synthetase activity of the encoded (p)ppGpp-synthetase/hydrolase. Moreover, among several other genes that were affected in the cdaA suppressor mutants, some suppressors had acquired mutations in the pycA pyruvate carboxylase gene and in the cbpB and pstA genes encoding the c-di-AMP receptor proteins CbpB and PstA, respectively (Whiteley et al. 2015). It has been suggested that the reduced conversion of GTP to (p)ppGpp by Rel stimulates the GTP-responsive transcriptional regulator CodY to represses the opp genes, which in turn would prevent the influx of oligopeptides to toxic levels (Fig. 1) (Stenz et al. 2011, Whiteley et al. 2015, Wang et al. 2022). Thus, c-di-AMP is required by L. monocytogenes to adjust the cellular turgor that is influenced by amino acids and peptides (Fig. 1) (Maria-Rosario et al. 1995, Commichau et al. 2018). This idea is supported by the finding that c-di-AMP also binds to and inhibits the ATPase subunit of the importer OpuC that transports the osmolyte carnitine (Huynh et al. 2016). Moreover, the L. monocytogenes cdaA mutant shows a strong lytic phenotype, which can be partially rescued by enhanced peptidoglycan biosynthesis that stabilizes the cell envelope (Wang et al. 2022). Recently, the underlying molecular mechanism of c-di-AMP-dependent control of (p)ppGpp synthesis has been elucidated in L. monocytogenes (Peterson et al. 2020). During growth in rich medium, c-di-AMP binds to and hinders CbpB from activating the synthesis of (p)ppGpp by Rel and a high GTP pool allows the CodY-dependent control of oligopeptide uptake. (Fig. 1). Thus, an essential function of c-di-AMP in L. monocytogenes is the control of the Opp system-mediated uptake of oligopeptides, which serve as a source of nutrients and influence the turgor of the cell (Maria-Rosario et al. 1995, Borezee et al. 2000, Commichau et al. 2018). The Opp system is also involved in the uptake of the epoxid antibiotic fosfomycin that targets the essential MurA enzyme (Kahan et al. 1974, Chekan et al. 2016), which catalyzes the committing reaction in peptidoglycan synthesis by (Fig. 1) (Wang et al. 2022). Thus, the promiscuous Opp system contributes together with the sugar phosphate permease Hpt to fosfomycin uptake in L. monocytogenes (Scortti et al. 2006, 2018).

Like in L. monocytogenes, c-di-AMP also plays a central role in the regulation of the cellular turgor in other bacteria (Commichau et al. 2018, Stülke and Krüger 2020). In B. subtilis, an essential function of c-di-AMP in B. subtilis is the control of the uptake of potassium ions via high- and low affinity potassium transport systems (Gundlach et al. 2017). Moreover, amino acids such as histidine, which is converted to glutamate, and glutamate itself were found to be toxic for a c-di-AMP B. subtilis mutant (Kimhi and Magasanik 1970, Krüger et al. 2021b, Meißner et al. 2022). Furthermore, suppressor mutants of the c-di-AMP-free B. subtilis mutant that grew in rich medium could only be isolated when one of the two c-di-AMP receptor proteins DarA (PstA in L. monocytogenes and S. aureus) or DarB (CbpB in L. monocytogenes) were absent (Krüger et al. 2021b). Interestingly, in B. subtilis, apo-DarB activates the tricarboxylic acid cycle (TCA)-replenishing pyruvate carboxylase PycA and, like in L. monocytogenes, also the (p)ppGpp-synthetase/hydrolase Rel (Krüger et al. 2021a, 2022). In L. monocytogenes, c-di-AMP directly binds to and activates PycA (Sureka et al. 2014). Thus, bacteria need to couple central metabolism with osmoregulation for growth in the presence of osmolytes such as potassium, amino acids and peptides (Whiteley et al. 2015, 2017, Krüger et al. 2022, Wang et al. 2022). This hypothesis is supported by observations that the uncontrolled uptake of osmolytes is also detrimental for growth c-di-AMP-free mutants of C. difficile, S. aureus and Streptococcus agalactiae (Devaux et al. 2018a, Zeden et al. 2018, 2020, Oberkampf et al. 2022).

It is interesting to note that the genome of L. monocytogenes carries the ktrCD, kimA and kdpABC potassium transport system genes as well as the kdpDE two-component signaling system genes whose products are involved in the expression control of the kdpABC operon in bacteria like S. aureus (Moscoso et al. 2015, Gibhardt et al. 2019). The L. monocytogenes KtrCD and KimA potassium transporters were shown to mediate uptake of potassium ions when heterologously expressed in Escherichia coli (Gibhardt et al. 2019). Moreover, c-di-AMP binds to both transporters and inhibits their transport activity (Gibhardt et al. 2019). However, in contrast to B. subtilis and other bacteria, the growth of a c-di-AMP-free L. monocytogenes mutant was only slightly inhibited by high amounts of extracellular potassium ions (Gibhardt et al. 2019). Moreover, suppressors derived from the c-di-AMP-free L. monocytogenes strain rarely accumulate mutations in potassium transporter genes (Whiteley et al. 2015, Wang et al. 2022). Thus, the physiological impact of the c-di-AMP-dependent regulation of potassium uptake seems to be less pronounced than in bacteria like B. subtilis (Gundlach et al. 2017, Devaux et al. 2018a, Oberkampf et al. 2022), and bacteria as well as archaea have evolved species-specific signaling systems of osmoregulation in which c-di-AMP serves as a key component.

Phenotypes of mutants of L. Monocytogenes and related bacteria with defects in c-di-AMP metabolism

Several studies revealed that the lack and the accumulation of c-di-AMP can be detrimental for the cell. However, many phenotypes related to perturbation of c-di-AMP metabolism are now better understood such as the inverse correlation between the cellular c-di-AMP levels and susceptibility of cell wall-targeting antibiotics (Luo and Helmann 2012, Witte et al. 2013, Whiteley et al. 2017, Commichau et al. 2018, Wang et al. 2022). It is now obvious that the cellular turgor likely increases in the absence of c-di-AMP due to the uncontrolled influx of osmolytes such as potassium ions, glycine betaine, carnitine, amino acids and peptides (Commichau et al. 2018, Stülke and Krüger 2020). Due to the turgor increase, the cell wall likely gets overstrained and thus more susceptible to cell wall-targeting antibiotics (Luo and Helmann 2012, Witte et al. 2013, Commichau et al. 2018, Pham et al. 2018, Zeden et al. 2018). By contrast, a drop in turgor due to reduced osmolyte uptake makes the cell less susceptible to antibiotics because the cell wall does not have to be as stable. Thus, in many cases, perturbation of c-di-AMP metabolism indirectly affects the integrity of the cell envelope. However, a direct link between c-di-AMP and cell wall metabolism has been identified in Streptomyces coelicolor (St Onge and Elliot 2017). Moreover, a recent study revealed that a L. monocytogenes gdpP pgpH mutant, which is unable to degrade c-di-AMP was impaired in peptidoglycan muropeptide and D-alanine-D-alanine synthesis (Massa et al. 2020). Since it was found that potassium stimulates the activity of the D-alanine-D-alanine ligase Dld, it was suggested that the reduced uptake of potassium due to c-di-AMP accumulation is responsible for the observed phenotype (Massa et al. 2020). Thus, in addition to the characterized potassium transporters KtrCD and KimA, probably yet unknown routes for potassium uptake such as the Kdp system exist in L. monocytogenes that are regulated by c-di-AMP.

Prior to the discovery of c-di-AMP, it was observed that the Opp oligopeptide transport system is required for growth of L. monocytogenes in rich medium at low temperatures (Borezee et al. 2000). Moreover, a L. monocytogenes transposon mutant that likely does not produce C-terminally located HD phosphohydrolase domain of the phosphodiesterase PgpH showed a cold-sensitive growth phenotype (Liu et al. 2006). Since it is now known that c-di-AMP indirectly controls the expression of the opp genes via CbpB and Rel, the temperature-dependent growth defect of the pgpH mutant might be caused by a lower abundance of the Opp transport system (Fig. 1). The surprising observation that this mutant synthesized slightly more (p)ppGpp is inconsistent with the model that c-di-AMP inhibits the formation of the alarmone by Rel (Fig. 1) (Peterson et al. 2020, Krüger et al. 2021a). However, this needs to be further investigated because the experimental design did not allow a precise quantification of the (p)ppGpp levels. In L. lactis it has been observed that spontaneous mutants, which grew better at elevated temperatures (37.5°C), had inactivated the gdpP phosphodiesterase gene (Smith et al. 2012). Thus, the link between the temperature sensitivity and c-di-AMP metabolism is still unclear.

Recently, it has been observed that isoleucine is toxic for a c-di-AMP-free L. monocytogenes mutant (Wang et al. 2022). The toxicity of isoleucine can be abolished by mutations in codY that alter the DNA-binding activity of the isoleucine- and GTP-responsive CodY protein (Wang et al. 2022). One of the isolated isoleucine-tolerant cdaA suppressor mutants acquired a mutation in the lmo2419 gene encoding the ATP-binding subunit of a putative amino acid ABC transporter. According to Uniprot, Lmo2419 is part of a putative methionine transporter. It needs to be elucidated whether the putative amino acid ABC transporter is involved in the uptake of isoleucine, methionine and other amino acids.

c-di-AMP targets of unknown function in L. Monocytogenes

In L. monocytogenes, there are still at least two c-di-AMP receptor proteins of unknown function, among them the PII-like PstA protein (DarA in B. subtilis) that has been biochemically and structurally characterized (Fig. 1) (Sureka et al. 2014, Choi et al. 2015, Gundlach et al. 2015a). The fact that some L. monocytogenes cdaA suppressor mutants, which gained the ability to grow in rich medium (Whiteley et al. 2017), acquired mutations in the pstA gene indicates that, like the CbpB protein, also PstA only exerts its function in the absence of c-di-AMP. This also holds true for B. subtilis because suppressor mutants of a c-di-AMP-free mutant that grew in rich medium could only be isolated when the darA gene was deleted (Krüger et al. 2021b). Potential interaction partners of PstA (or DarA) could therefore perhaps be identified via an in vivo crosslinking approach when the cdaA cells are transferred from minimal medium to rich medium.

Much less is known about the c-di-AMP receptor protein CbpA, which is a poorly conserved protein and has no counterpart in B. subtilis and S. aureus (Fig. 1). Like CbpB, CbpA contains a CBS (cystathione-beta-synthase) domain that was first defined for the cystathione beta synthase (Baykov et al. 2011, Ereno-Orbea et al. 2013). CbpA also contains an ACT (aspartate kinase-chorismate mutase-tyrA (prephrenate dehydrogenase) (ACT) domain (http://www.uniprot.org)). The ACT domain serves as a regulatory module for small ligand-dependent allosteric regulation of enzymes that are often involved in amin acid and purine biosynthesis (Liberles et al. 2005, Grant 2006). Structural analysis of CbpA allowed the construction of a sensor to assess the intracellular concentrations of c-di-AMP (Pollock et al. 2021).

Recently, it has been observed that a L. monocytogenes mutant that constitutively expresses the virulence genes depends on CbpA and two other proteins to cope with oxidative stress (Mains et al. 2021). However, the fact that the cbpA gene did not appear in any previous suppressor analysis makes it difficult to define a meaningful experimental approach for finding its function.

Control of c-di-AMP Synthesis in L. Monocytogenes

It is unequivocally clear that c-di-AMP plays a crucial role in the adaptation of bacteria and archaea to the osmolarity of the environment. However, it is not yet understood how the cell senses the environmental osmolarity to adjust the intracellular c-di-AMP levels that control osmolyte uptake and export, and thus the turgor. It has previously been shown that the activity of CdaA is modulated by the membrane-attached CdaR protein that directly interacts with the diadenylate cyclase (Fig. 1) (Table 1). However, it is unclear whether CdaR activates or inhibits CdaA. Since CdaR is exposed to the cell surface and gets into contact with the peptidoglycan layer, the protein might sense cell wall damage or the tension of the cell envelope and adjust the turgor of the cell by controlling the CdaA-dependent c-di-AMP synthesis. Recently, it has been demonstrated that intrinsically disordered proteins like the membrane-anchored cell surface-exposed anti-σ factor RsgI, which controls SigI activity, are required for cell wall homeostasis in B. subtilis (Brunet et al. 2022). When cell wall biosynthesis is impaired, RsgI, which is constitutively processed into an ectodomain and a membrane part by proteolytic cleavage, triggers activation of the SigI regulon (Brunet et al. 2022). It is tempting to speculate that CdaR senses the integrity of the cell wall like RsgI and transmits the signal to CdaA.

Table 1.

Confirmed interactions between CdaR, CdaA, GlmM in Firmicutes.

Organism Analyzed protein pair Interaction/methods Effect on c-di-AMP synthesis References
B. subtilis CdaR-CdaA Yes/BTHa and activity assay Activation, in vivo (tested in Escherichia coli) Mehne et al. 2013, Gundlach et al. 2015a
GlmM-CdaA Yes/BTH assay, SPINEb, FPLCc, SAXSd and structure analysis, activity assay Inhibition, in vitro Gundlach et al. 2015b, Pathania et al. 2021
L. monocytogenes CdaR-CdaA Yes/BTH assay, activity assay Inhibition, in vivo (tested in E. coli and L. monocytogenes) Rismondo et al. 2016, Gibhardt et al. 2020
GlmM-CdaA Yes/BTH assay, pulldown assay, SEC-MALSe, ITCf, activity assay Inhibition, in vivo (tested in E. coli and in L. monocytogenes) and in vitro Gibhardt et al. 2020
L. lactis CdaR-CdaA Activity assay No effecth Zhu et al., 2015
GlmM-CdaA Yes/BTH assay, Inhibition in vivo (tested in E. coli and L. lactis) Zhu et al., 2015
S. aureus CdaR-CdaA Activity assay Inhibition in vivo (tested in E. coli) Zhu et al., 2015
GlmM-CdaA SAXSd, SECg, pulldown assay, activity assay Inhibition in vivo (tested in E. coli) and in vitro Tosi et al. 2019
a

Bacterial two-hybrid assay.

b

Strep-protein interaction experiment, in vivo crosslinking in combination with a pulldown assay.

c

Fast protein liquid chromatography.

d

Small-angle X-ray scattering.

e

Size-exclusion chromatography and multiangle light scattering.

f

Isothermal titration calorimetry.

g

Size-exclusion chromatography

h

cdaR is a pseudogene in the L. lactis strain MG1363 (Zhu et al. 2016).

As mentioned above, the cdaR, cdaA and glmM genes are part of the cdaRA-glmM module that is conserved in many bacteria synthesizing c-di-AMP (Corrigan and Gründling 2013, Pham et al. 2016). Like CdaR, also GlmM interacts with and inhibits CdaA in B. subtilis, L. monocytogenes, L. lactis, and S. aureus (Fig. 1) (Table 1). Structural characterization of a complex consisting of the soluble C-terminal CdaA domain and GlmM from B. subtilis revealed that GlmM prevents the formation of active head-to-head CdaA oligomers (Pathania et al. 2021). Moreover, in L. monocytogenes, the GlmM-dependent inhibition is triggered during growth of the bacteria in a hyperosmotic environment (Gibhardt et al. 2020). It has been suggested that the cell volume changes in response to an osmotic up- or downshifts could result in a transient change of the cellular GlmM concentration, which would facilitate the interaction with CdaA and thus the control of c-di-AMP synthesis (Gibhardt et al. 2020). However, this hypothesis needs to be verified. In contrast to L. monocytogenes, B. subtilis synthesizes the two vegetative diadenylate cyclases CdaA and DisA as well as the sporulation specific enzyme CdaS (Luo and Helmann 2012, Mehne et al. 2013). Interestingly, B. subtilis only needs a single c-di-AMP-producing enzyme for growth in rich medium (Mehne et al. 2013, 2014). This indicates that CdaA, DisA and a hyperactive variant of CdaS can functionally replace each other, and that the synthesis of c-di-AMP does not have to take place at the membrane. For L. monocytogenes it has been shown that the native diadenylate cyclase CdaA can be replaced by DisA from B. subtilis (Witte et al. 2013). Thus, like CdaA, also the soluble diadenylate cyclase DisA and CdaS may respond to changes in environmental osmolarity. In the case of DisA, one might hypothesize that changes in the viscosity of the cytoplasm depending on the osmolarity of the environment facilitate the inhibitory interaction between the diadenylate cyclase and DNA, and thus c-di-AMP production. However, also this idea needs to be verified.

Open questions

As mentioned above, the cellular functions of the c-di-AMP receptor proteins PstA and CbpA must be identified. The importance of c-di-AMP for osmolyte homeostasis and central metabolism only becomes apparent when the functions of all targets are known. The most exciting question how the cell ‘senses’ the environmental osmolarity to adjust the cellular turgor using c-di-AMP remains to be addressed. The identification of the signals that are sensed by the diadenylate cyclases and the phosphodiesterase may provide an answer to this important question. Moreover, the link between c-di-AMP metabolism and cell wall homeostasis needs to be investigated.

ACKNOWLEDGEMENTS

We are grateful to the members of the Commichau laboratory for fruitful comments and suggestions. We thank Jörg Stülke for sparking our interest in the second messenger c-di-AMP. We are also grateful to Regine Hengge who established the priority program of the SPP1879 in Germany.

Contributor Information

Inge Schwedt, FG Microbiology, Molecular Microbiology, Institute of Biology, University of Hohenheim, 70599 Stuttgart, Germany.

Mengyi Wang, FG Microbiology, Molecular Microbiology, Institute of Biology, University of Hohenheim, 70599 Stuttgart, Germany.

Johannes Gibhardt, FG Microbiology, Molecular Microbiology, Institute of Biology, University of Hohenheim, 70599 Stuttgart, Germany.

Fabian M Commichau, FG Microbiology, Molecular Microbiology, Institute of Biology, University of Hohenheim, 70599 Stuttgart, Germany.

Conflict of interest statement

The authors declare no conflict of interest.

Funding

This work was supported by the Grant Co 1139/2–2 of the Deutsche Forschungsgemeinschaft to F. M. C.

References

  1. Andrade WA, Firon A, Schmidt Tet al. Group B Streptococcus degrades cyclic-di-AMP to modulate STING-dependent type I interferon production. Cell Host Microbe. 2016;20:49–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bai Y, Yang J, Zhou Xet al. Mycobacterium tuberculosis Rv3586 (DacA) is a diadenylate cyclase that converts ATP or ADP into c-di-AMP. PLoS One. 2012;7:e35206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bai Y, Yang J, Eisele LEet al. Two DHH subfamily 1 proteins in Streptococcus pneumoniae possess cyclic di-AMP phosphodiesterase activity and affect bacterial growth and virulence. J Bacteriol. 2013;195:5123–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bai Y, Yang J, Zarrella TMet al. Cyclic di-AMP impairs potassium uptake mediated by a cyclic di-AMP binding protein in Streptococcus pneumoniae. J Bacteriol. 2014;196:614–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bandera AM, Bartho J, Lammens Ket al. BusR senses bipartite DNA binding motifs by a unique molecular ruler architecture. Nucleic Acids Res. 2021;49:10166–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Barker JR, Koestler BJ, Carpenter VKet al. STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during Chlamydia trachomatis infection. Mbio. 2013;4:e00018–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Baykov AA, Tuominen HK, Lahti R. The CBS domain: a protein module with an emerging prominent role in regulation. ACS Chem Biol. 2011;6:1156–63. [DOI] [PubMed] [Google Scholar]
  8. Bejerano-Sagie M, Oppenheimer-Shaanan Y, Berlatzky Iet al. A checkpoint protein that scans the chromosome for damage at the start of sporulation in Bacillus subtilis. Cell. 2006;125:679–90. [DOI] [PubMed] [Google Scholar]
  9. Block KF, Hammond MC, Breaker RR. Evidence for widespread gene control function by the ydaO riboswitch candidate. J Bacteriol. 2010;192:3983–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Blötz C, Treffon K, Kaever Vet al. Identification of the components involved in cyclic di-AMP signaling in Mycoplasma pneumoniae. Front Microbiol. 2017;8:1328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Borezee E, Pellegrini E, Berche P. OppA of Listeria monocytogenes, an oligopeptide-binding protein required for bacterial growth at low temperature and involved in intracellular survival. Infect Immun. 2000;68:7069–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bowman L, Zeden MS, Schuster CFet al. New insights into the cyclic di-adenosine monophosphate (c-di-AMP) degradation pathway and the requirement of the cyclic dinucleotide for acid stress resistance in Staphylococcus aureus. J Biol Chem. 2016;291:26970–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Braun F, Thomalla L, van der Does Cet al. Cyclic nucleotides in archaea: cyclic di-AMP in the archaeon Haloferax volcanii and its putative role. Microbiologyopen. 2019;8:e00829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Braun F, Recalde A, Bähre Het al. Putative nucleotide-based second messengers in the archaeal model organisms Haloferax volcanii and Sulfolobus acidocaldarius. Front Microbiol. 2021;12:779012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Burnet YR, Habib C, Brogan APet al. Intrinsically disordered protein regions are required for cell wall homeostasis in Bacillus subtilis. Genes Dev. 2022;36:970–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Campeotto I, Zhang Y, Mladenov MGet al. Complex structure and biochemical characterization of the Staphylococcus aureus cyclic diadenylate monophosphate (c-di-AMP)-binding protein PstA, the founding member of a new signa transduction protein family. J Biol Chem. 2015;290:2888–901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cereija TB, Guerra JPL, Jorge JMPet al. c-di-AMP, a likely master regulator of bacterial K(+) homeostasis machinery, activates a K(+) exporter. Proc Natl Acad Sci. 2021;118:e2020653118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Chekan JR, Cogan DP, Nair SK. Molecular basis for resistance against phosphonate antibiotics and herbicides. MedChemComm. 2016;7:28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Chin KH, Liang JM, Yang JGet al. Structural insights into the distinct binding mode of cyclic di-AMP with SaCpaA-RCK. Biochemistry. 2015;54:4936–51. [DOI] [PubMed] [Google Scholar]
  20. Choi PH, Sureka K, Woodward JJet al. Molecular basis for the recognition of cyclic-di-AMP by PstA, a PII-like signal transduction protein. Microbiologyopen. 2015;4:361–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Choi PH, Vu TMN, Pham HTet al. Structural and functional studies of pyruvate carboxylase regulation by cyclic di-AMP in lactic acid bacteria. Proc Natl Acad Sci. 2017;114:E7226–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Commichau FM, Gibhardt J, Halbedel Set al. A delicate connection: c-di-AMP affects cell integrity by controlling osmolyte transport. Trends Microbiol. 2018;26:175–85. [DOI] [PubMed] [Google Scholar]
  23. Commichau FM, Heidemann JL, Ficner Ret al. Making and breaking of an essential poison: the cyclases and phosphodiesterases that produce and degrade the essential second messenger cyclic di-AMP in bacteria. J Bacteriol. 2019;201:e00462–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Corrigan RM, Abbott JC, Burhenne Het al. c-di-AMP is a new second messenger in Staphylococcus aureus with a role in controlling cell size and envelope stress. PLoS Pathog. 2011;7:e1002217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Corrigan RM, Gründling A. Cyclic di-AMP: another second messenger enters the fray. Nat Rev Microbiol. 2013;11:513–24. [DOI] [PubMed] [Google Scholar]
  26. Corrigan RM, Campeotto I, Jeganathan Tet al. Systematic identification of conserved bacterial c-di-AMP receptor proteins. Proc Natl Acad Sci. 2013;110:9084–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Corrigan RM, Bowman L, Willis ARet al. Cross-talk between two nucleotide-signaling pathways in Staphylococcus aureus. J Biol Chem. 2015;290:5826–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Crimmins GT, Herskovits AA, Rehder Ket al. Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity. Proc Natl Acad Sci. 2008;105:10191–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Devaux L, Kaminski PA, Trieu-Cout Pet al. Cyclic di-AMP in host-pathogen interactions. Curr Opin Microbiol. 2018. b;41:21–28. [DOI] [PubMed] [Google Scholar]
  30. Devaux L, Sleiman D, Mazzuoli MVet al. Cyclic di-AMP regulation of osmotic homeostasis is essential in group B Streptococcus. PLos Genet. 2018. a;14:e1007342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Du B, Ji W, An Het al. Functional analysis of c-di-AMP phosphodiesterase, GdpP, in Streptococcus suis serotype 2. Microbiol Res. 2014;169:749–58. [DOI] [PubMed] [Google Scholar]
  32. Ereno-Orbea J, Oyenarte I, Martinez-Cruz LA. CBS domains: ligand binding sites and conformational variability. Arch Biochem Biophys. 2013;540:70–81. [DOI] [PubMed] [Google Scholar]
  33. Fahmi T, Faozia S, Port GCet al. The second messenger c-di-AMP regulates diverse cellular pathways involved in stress response, biofilm formation, cell wall homeostasis, SpeB expression, and virulence in Streptococcus pyogenes. Infect Immun. 2019;87:e00147–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Faozia S, Fahmi T, Port GCet al. c-di-AMP-regulated K+ importer KtrAB affects biofilm formation, stress response, and SpeB expression in Streptococcus pyogenes. Infect Immun. 2021;89:e00317–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Fischer MA, Engelgeh T, Rothe Pet al. Listeria monocytogenes genes supporting growth under standard laboratory cultivation conditions and during macrophage infection. Genome Res. 2022;32:1711–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Gall AR, Hsueh BY, Siletti Cet al. NrnA is a linear dinucleotide phosphodiesterase with limited function in cyclic dinucleotide metabolism in Listeria monocytogenes. J Bacteriol. 2022;204:e0020621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Gándara C, Alonso JC. DisA and c-di-AMP act at the intersection between DNA-damage response and stress homeostasis in exponentially growing Bacillus subtilis cells. DNA Repair (Amst). 2015;27:1–8. [DOI] [PubMed] [Google Scholar]
  38. Gao A, Serganov A. Structural insights into recognition of c-di-AMP by the ydaO riboswitch. Nat Chem Biol. 2014;10:787–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Gibhardt J, Hoffmann G, Turdiev Aet al. c-di-AMP assists osmoadaptation by regulating the Listeria monocytogenes potassium transporters KimA and KtrCD. J Biol Chem. 2019;294:16020–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Gibhardt J, Heidemann JL, Bremenkamp Ret al. An extracytoplasmic protein and a moonlighting enzyme modulate synthesis of c-di-AMP in Listeria monocytogenes. Environ Microbiol. 2020;22:2771–91. [DOI] [PubMed] [Google Scholar]
  41. Grant GA. The ACT domain: a small molecule binding domain and its role as a common regulatory element. J Biol Chem. 2006;281:33825–9. [DOI] [PubMed] [Google Scholar]
  42. Gundlach J, Dickmanns A, Schröder-Tittmann Ket al. Identification, characterization, and structure analysis of the cyclic di-AMP-binding PII-like signal transduction protein DarA. J Biol Chem. 2015. a;290:3069–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Gundlach J, Mehne FM, Herzberg Cet al. An essential poison: synthesis and degradation of cyclic di-AMP in Bacillus subtilis. J Bacteriol. 2015. b;197:3265–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Gundlach J, Rath H, Herzberg Cet al. Second messenger signaling in Bacillus subtilis: accumulation of cyclic di-AMP inhibits biofilm formation. Front Microbiol. 2016;7:804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Gundlach J, Herzberg C, Kaever Vet al. Control of potassium homeostasis is an essential function of the second messenger cyclic di-AMP in Bacillus subtilis. Sci Signal. 2017;10:eaal3011. [DOI] [PubMed] [Google Scholar]
  46. He J, Yin W, Galperin MYet al. Cyclic di-AMP, a second messenger of primary importance: tertiary structures and binding mechanisms. Nucleic Acids Res. 2020;48:2807–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Heidemann JL, Neumann P, Dickmanns Aet al. Crystal structures of the c-di-AMP-synthesizing enzyme CdaA. J Biol Chem. 2019;294:10463–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Huynh TN, Woodward JJ. Too much of a good thing: regulated depletion of c-di-AMP in the bacterial cytoplasm. Curr Opin Microbiol. 2016;30:22–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Huynh TN, Luo S, Pensinger Det al. An HD-domain phosphodiesterase mediates cooperative hydrolysis of c-di-AMP to affect bacterial growth and virulence. Proc Natl Acad Sci. 2015;112:E747–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Huynh TN, Choi PH, Sureka Ket al. Cyclic di-AMP targets the cystathione beta-synthase domain of the osmolyte transporter OpuC. Mol Microbiol. 2016;102:233–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Kahan FM, Kahan JS, Cassidy PJet al. The mechanism of action of fosfomycin (phosphonomycin). Ann NY Acad Sci. 1974;235:364–86. [DOI] [PubMed] [Google Scholar]
  52. Kaplan Zeevi M, Shafir NS, Shaham Set al. Listeria monocytogenes multidrug resistance transporters and cyclic di-AMP, which contribute to type I interferon induction, play a role in cell wall stress. J Bacteriol. 2013;195:5250–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Kellenberger CA, Chen C, Whiteley ATet al. RNA-based fluorescent biosensors for live cell imaging of second messenger cyclic di-AMP. J Am Chem Soc. 2015;137:6432–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Kimhi Y, Magasanik B. Genetic basis for histidine degradation in Bacillus subtilis. J Biol Chem. 1970;245:3545–8. [PubMed] [Google Scholar]
  55. Krüger L, Herzberg C, Warneke Ret al. Two ways to convert a low-affinity potassium channel to high affinity: control of Bacillus subtilis KtrCD by glutamate. J Bacteriol. 2020;202:e00138–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Krüger L, Herzberg C, Wicke Det al. A meet-up oft wo second messengers: the c-di-AMP receptor DarB controls (p)ppGpp synthesis in Bacillus subtilis. Nat Commun. 2021a;12:1210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Krüger L, Herzberg C, Rath Het al. Essentiality of c-di-AMP in Bacillus subtilis: bypassing mutations converging in potassium and glutamate homeostasis. PLos Genet. 2021b;17:e1009092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Krüger L, Herzberg C, Wicke Det al. Sustained control of pyruvate carboxylase by the essential second messenger cyclic di-AMP in Bacillus subtilis. Mbio. 2022;13:e0360221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Latoscha A, Drexler DJ, Al-Bassam MMet al. c-di-AMP hydrolysis by the phosphodiesterase AtaC promotes differentiation of multicellular bacteria. Proc Natl Acad Sci. 2020;117:7392–400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Liberles JS, Thórólfsson M, Marínez A. Allosteric mechanisms in ACT domain containing enzymes involved in amino acid metabolism. Amino Acids. 2005;28:1–12. [DOI] [PubMed] [Google Scholar]
  61. Liu S, Bayles DO, Mason TMet al. A cold-sensitive Listeria monocytogenes mutant has a transposon insertion in a gene encoding a putative membrane protein and shows altered (p)ppGpp levels. Appl Environ Microbiol. 2006;72:3955–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Luo Y, Helmann JD. Analysis of the role of Bacillus subtilis sigma(M) in beta-lactam resistance reveals an essential role for c-di-AMP in peptidoglycan homeostasis. Mol Microbiol. 2012;83:623–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Mains DR, Eallonardo SJ, Freitag NE. Identification of Listeria monocytogenes genes contributing to oxidative stress resistance under conditions relevant to host infection. Infect Immun. 2021;89:e00700–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Manikandan K, Sabareesh V, Singh Net al. Two-step synthesis and hydrolysis of cyclic di-AMP in Mycobacterium tuberculosis. PLoS One. 2014;9:e86096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Maria-Rosario A, Davidson I, Debra Met al. The role of peptide metabolism in the growth of Listeria monocytogenes ATCC 23074 at high osmolarity. Microbiology. 1995;141:41–49. [DOI] [PubMed] [Google Scholar]
  66. Massa SM, Sharma AD, Siletti Cet al. c-di-AMP accumulation impairs muropeptide synthesis in Listeria monocytogenes. J Bacteriol. 2020;202:e00307–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Mehne FM, Gunka K, Eilers Het al. Cyclic di-AMP homoeostasis in Bacillus subtilis: both lack and high level accumulation of the nucleotide are detrimental for cell growth. J Biol Chem. 2013;288:2004–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Mehne FM, Schröder-Tittmann K, Eijlander RTet al. Control of diadenylate cyclase CdaS in Bacillus subtilis: an autoinhibitory domain limits cyclic di-AMP production. J Biol Chem. 2014;289:21098–107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Meißner J, Schramm T, Hoßbach Bet al. How to deal with toxic amino acids: the bipartite AzlCD complex exports histidine in Bacillus subtilis. J Bacteriol. 2022;204:e0035322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Moscoso JA, Schramke H, Zhang Yet al. Binding of cyclic di-AMP to the Staphylococcus aureus sensor kinase KdpD occurs via the universal stress protein domain and downregulates the expression of the kdp potassium transporter. J Bacteriol. 2015;198:98–110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Müller M, Hopfner KP, Witte G. c-di-AMP recognition by Staphylococcus aureus PstA. FEBS Lett. 2015;589:45–51. [DOI] [PubMed] [Google Scholar]
  72. Nelson JW, Sudarsan N, Furukuwa Ket al. Riboswitches in eubacteria sense the second messenger c-di-AMP. Nat Chem Biol. 2013;9:834–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Oberkampf M, Hamiot A, Altamirano-Silva Pet al. C-di-AMP signaling is required for bile salt resistance, osmotolerance, and long-term host colonization by Clostridioides difficile. Sci Signal. 2022;15:eabn8171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Pathania M, Tosi T, Millership Cet al. Structural basis for the inhibition of the Bacillus subtilis c-di-AMP cyclase CdaA by the phosphoglucomutase GlmM. J Biol Chem. 2021;297:101317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Peng X, Zhang Y, Bai Get al. Cyclic di-AMP mediates biofilm formation. Mol Microbiol. 2016;99:945–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Peterson BN, Young MKM, Luo Set al. (p)ppGpp and c-di-AMP homeostasis is controlled by CbpB in Listeria monocytogenes. Mbio. 2020;11:e1625–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Pham TH, Liang ZX, Marcellin Eet al. Replenishing the cyclic-di-AMP pool: regulation of diadenylate cyclase activity in bacteria. Curr Genet. 2016;62:731–8. [DOI] [PubMed] [Google Scholar]
  78. Pham HT, Nhiep NTH, Vu TNMet al. Enhanced uptake of potassium or glycine betaine or export of cyclic-di-AMP restores osmoresistance in a high cyclic-di-AMP lactococcus lactis mutant. PLos Genet. 2018;14:e1007574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Pham HT, Shi W, Xiang Yet al. Cyclic di-AMP oversight of counter-ion osmolyte pools impacts intrinsic cefuroxime resistance in lactococcus lactis. Mbio. 2021;12:e00324–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Pollock AJ, Choi PH, Zaver SAet al. A rationally designed c-di-AMP Förster resonance energy transfer biosensor to monitor nucleotide dynamics. J Bacteriol. 2021;203:e0008021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Quintana IM, Gibhardt J, Turdiev Aet al. The KupA and KupB proteins of Lactococcus lactis IL1403 are novel c-di-AMP receptor proteins responsible for potassium uptake. J Bacteriol. 2019;201:e00028–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Ren A, Patel DJ. c-di-AMP binds the ydaO riboswitch in two pseudo-symmetry-related pockets. Nat Chem Biol. 2014;10:780–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Rismondo J, Gibhardt J, Rosenberg Jet al. Phenotypes associated with the essential diadenylate cyclase CdaA and its potential regulator CdaR in the human pathogen Listeria monocytogenes. J Bacteriol. 2016;198:416–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Rallu F, Gruss A, Ehrlich SDet al. Acid- and intracellular-resistant mutants of Lactococcus lactis: identification of intracellular stress signals. Mol Microbiol. 2000;35:517–28. [DOI] [PubMed] [Google Scholar]
  85. Rao F, See RY, Zhang Det al. YybT is a signaling protein that contains a cyclic dinucleotide phosphodiesterase domain and a GGDEF domain with atpase activity. J Biol Chem. 2010;285:473–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Rao F, Ji Q, Soehano Iet al. Unusual heme-binding PAS domain from YybT family proteins. J Bacteriol. 2011;193:1543–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Rorvik GH, Naemi AO, Edvardsen PKTet al. The c-di-AMP signaling system influences stress tolerance and biofilm formation of Streptococcus mitis. Microbiologyopen. 2021;10:e1203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Rosenberg J, Dickmanns A, Neumann Pet al. Structural and biochemical analysis of the essential diadenylate cyclase CdaA from Listeria monocytogenes. J Biol Chem. 2015;290:6596–606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Rubin BE, Huynh TN, Welkie DGet al. High-throughput interaction screens illuminate the role of c-di-AMP in cyanobacterial nighttime survival. PLos Genet. 2018;14:e1007301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Schuster CF, Bellows LE, Tosi Tet al. The second messenger c-di-AMP inhibits the osmolyte uptake system OpuC in Staphylococcus aureus. Sci Signal. 2016;9:ra81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Schwartz KT, Carleton JD, Quillin SJet al. Hyperinduction of host beta interferon by a Listeria monocytogenes strain naturally overexpressing the multidrug efflux pump MdrT. Infect Immun. 2012;80:1537–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Scortti M, Lacharme-Lora L, Wagner Met al. Coexpression of virulence and fosfomycin susceptibility in Listeria: molecular basis of an antimicrobial in vitro-in vivo paradox. Nat Med. 2006;12:515–7. [DOI] [PubMed] [Google Scholar]
  93. Scortti M, Han L, Alvarez Set al. Epistatic control of intrinsic resistance by virulence genes in Listeria. PLos Genet. 2018;14:e1007525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Selim KA, Haffner M, Burkhardt Met al. Diurnal metabolic control in cyanobacteria requires perception of second messenger signaling molecule c-di-AMP by the carbon control protein SbtB. Sci Adv. 2021;7:eabk0568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Sikkema HR, van den Noort M, Rheinberger Jet al. Gating by ionic strength and safety check by cyclic-di-AMP in the. ABC Transporter OpuA Sci Adv. 2020;6:eabd7697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Smith WM, Pham TH, Lei Let al. Heat resistance and salt hypersensitivity in Lactococcus lactis due to spontaneous mutation of llmg_1816 (gdpP) induced by high-temperature growth. Appl Environ Microbiol. 2012;78:7753–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. St-Onge RJ, Elliot MA. Regulation of a muralytic enzyme-encoding gene by two non-coding rnas. RNA Biology. 2017;14:1592–605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Stenz L, Francois P, Whiteson Ket al. The CodY pleiotropic repressor controls virulence in gram-positive pathogens. FEMS Immunol Med Microbiol. 2011;62:123–39. [DOI] [PubMed] [Google Scholar]
  99. Stülke J, Krüger L. Cyclic di-AMP signaling in bacteria. Annu Rev Microbiol. 2020;74:159–79. [DOI] [PubMed] [Google Scholar]
  100. Sureka K, Choi PH, Precit Met al. The cyclic dinucleotide c-di-AMP is an allosteric regulator of metabolic enzyme function. Cell. 2014;158:1389–401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Tadmor K, Pozniak Y, Burg Golani Tet al. Listeria monocytogenes MDR transporters are involved in LTA synthesis and triggering of innate immunity during infection. Front Cell Infect Microbiol. 2014;4:16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Tan W, Rao F, Pasunooti Set al. Solution structure of the PAS domain of a thermophilic YybT protein homolog reveals a potential ligand-binding site. J Biol Chem. 2013;288:11949–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. The WK, Dramsi S, Tolker-Nielsen Tet al. Increased intracellular cyclic di-AMP levels sensitize Streptococcus gallolyticus subsp. Gallolyticus to osmotic stress and reduce biofilm formation and adherence on intestinal cells. J Bacteriol. 2019;201:e00597–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Tosi T, Hoshiga F, Millership Cet al. Inhibition of the Staphylococcus aureus c-di-AMP cyclase DacA by direct interaction with the phosphoglucosamine mutase GlmM. PLoS Pathog. 2019;15:e1007537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Townsley L, Yannarell SM, Huynh TNet al. Cyclic di-AMP acts as an extracellular signal that impacts Bacillus subtilis biofilm formation and plant attachment. Mbio. 2018;9:e00341–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Wang X, Davlieva M, Reyes Jet al. Novel phosphodiesterase of the GdpP family modulates cyclic di-AMP levels in response to cell membrane stress in daptomycin-resistant enterococci. Antimicrob Agents Chemother. 2017;61:e01422–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Wang X, Cai X, Ma Het al. A c-di-AMP riboswitch controlling kdpFABC operon transcription regulates the potassium transporter system in Bacillus thuringiensis. Communicat Biol. 2019;2:151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Wang M, Wamp S, Gibhardt Jet al. Adaptation of Listeria monocytogenes to perturbation of c-di-AMP metabolism underpins its role in osmoadaptation and identifies a fosfomycin uptake system. Environ Microbiol. 2022;24:4466–88. [DOI] [PubMed] [Google Scholar]
  109. Whiteley AT, Pollock AJ, Portnoy DA. The PAMP c-di-AMP is essential for Listeria monocytogenes growth in rich but not in minimal media due to a toxic increase in (p)ppGpp. Cell Host & Microbe. 2015;17:788–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Whiteley AT, Garelis NE, Peterson BNet al. c-di-AMP modulates Listeria monocytogenes central metabolism to regulate growth, antibiotic resistance and osmoregulation. Mol Microbiol. 2017;104:212–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Witte G, Hartung S, Büttner Ket al. Structural biochemistry of a bacterial checkpoint protein reveals diadenylate cyclase activity regulated by DNA recombination intermediates. Mol Cell. 2008;30:167–78. [DOI] [PubMed] [Google Scholar]
  112. Witte CE, Whiteley AT, Burke TPet al. Cyclic di-AMP is critical for Listeria monocytogenes growth, cell wall homeostasis, and establishment of infection. Mbio. 2013;4:e00282–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Woodward JJ, Lavarone AT, Portnoy DA. c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response. Science. 2010;328:1703–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Yamamoto T, Hara H, Tsuchiya Ket al. Listeria monocytogenes strain-specific impairment of the TetR regulator underlies the drastic increase in cyclic di-AMP secretion and beta interferon-inducing ability. Infect Immun. 2012;80:2323–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Yin W, Cai X, Ma Het al. A decade of research on the second messenger c-di-AMP. FEMS Microbiol Rev. 2020;44:701–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Zarrella TM, Yang J, Metzger DWet al. Bacterial second messenger cyclic di-AMP modulates the competence state in Streptococcus pneumoniae. J Bacteriol. 2020;202:e00691–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Zeden MS, Schuster CF, Bowman Let al. Cyclic di-adenosine monophosphate (c-di-AMP) is required for osmotic regulation in Staphylococcus aureus but dispensable for viability in anaerobic conditions. J Biol Chem. 2018;293:3180–200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Zeden MS, Kviatkovski I, Schuster Fet al. Indentification of the main glutamine and glutamate transporters in Staphylococcus aureus and their impact on c-di-AMP production. Mol Microbiol. 2020;113:1085–100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Zheng C, Wang J, Luo Yet al. Highly efficient enzymatic preparation of c-di-AMP using the diadenylate cyclase DisA from Bacillus thuringiensis. Enzyme Microb Technol. 2013;52:319–24. [DOI] [PubMed] [Google Scholar]
  120. Zhu Y, Pham TH, Nhiep THet al. Cyclic-di-AMP synthesis by the diadenylate cyclase CdaA is modulated by the peptidoglycan biosynthesis enzyme GlmM in Lactococcus lactis. Mol Microbiol. 2016;99:1015–27. [DOI] [PubMed] [Google Scholar]

Articles from microLife are provided here courtesy of Oxford University Press

RESOURCES